










<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://52.214.119.220/wiki/skins/common/feed.css?97"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>User:Alexis Walker/Sandbox 1 - Revision history</title>
		<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;action=history</link>
		<description>Revision history for this page on the wiki</description>
		<language>en</language>
		<generator>MediaWiki 1.11.2</generator>
		<lastBuildDate>Wed, 08 Apr 2026 17:50:24 GMT</lastBuildDate>
		<item>
			<title>Alexis Walker at 14:27, 30 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3202983&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:27, 30 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;2V83&lt;/del&gt;' size='&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;500&lt;/del&gt;' frame='true' align='right' caption='&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;3-D model of RAG2-PHD' scene='2V83&lt;/del&gt;'/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;2v83&lt;/ins&gt;' size='&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;300' color='white&lt;/ins&gt;' frame='true' align='right' caption='&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;2v83&lt;/ins&gt;' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key nuclear protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity&amp;lt;ref&amp;gt;Sadofsky MJ. The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res. 2001;29(7):1399–1409. doi:10.1093/nar/29.7.1399&amp;lt;/ref&amp;gt;. RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key nuclear protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity&amp;lt;ref&amp;gt;Sadofsky MJ. The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res. 2001;29(7):1399–1409. doi:10.1093/nar/29.7.1399&amp;lt;/ref&amp;gt;. RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 30 Apr 2020 14:27:00 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
		<item>
			<title>Alexis Walker at 14:12, 30 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3202981&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:12, 30 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='3-D model of RAG2-PHD' scene='2V83'/&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key nuclear protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity&amp;lt;ref&amp;gt;Sadofsky MJ. The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res. 2001;29(7):1399–1409. doi:10.1093/nar/29.7.1399&amp;lt;/ref&amp;gt;. RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key nuclear protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity&amp;lt;ref&amp;gt;Sadofsky MJ. The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res. 2001;29(7):1399–1409. doi:10.1093/nar/29.7.1399&amp;lt;/ref&amp;gt;. RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 30 Apr 2020 14:12:03 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
		<item>
			<title>Alexis Walker at 14:11, 30 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3202980&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:11, 30 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='3-D model of RAG2-PHD' scene='2V83'/&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 30 Apr 2020 14:11:50 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
		<item>
			<title>Alexis Walker at 14:06, 30 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3202979&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:06, 30 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='3-D model of RAG2-PHD' scene='2V83'/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='3-D model of RAG2-PHD' scene='2V83' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 30 Apr 2020 14:06:54 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
		<item>
			<title>Alexis Walker at 14:04, 30 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3202978&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:04, 30 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== 2V83 Recombination Activating Gene 2 ==&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='3-D model of RAG2-PHD' scene='2V83' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='3-D model of RAG2-PHD' scene='2V83' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 30 Apr 2020 14:04:03 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
		<item>
			<title>Alexis Walker at 13:58, 30 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3202975&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 13:58, 30 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== 2V83 Recombination Activating Gene 2 ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='3-D model of RAG2-PHD' scene='2V83' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='3-D model of RAG2-PHD' scene='2V83' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;2V83 Recombination Activating Gene 2&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key nuclear protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity&amp;lt;ref&amp;gt;Sadofsky MJ. The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res. 2001;29(7):1399–1409. doi:10.1093/nar/29.7.1399&amp;lt;/ref&amp;gt;. RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key nuclear protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity&amp;lt;ref&amp;gt;Sadofsky MJ. The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res. 2001;29(7):1399–1409. doi:10.1093/nar/29.7.1399&amp;lt;/ref&amp;gt;. RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 30 Apr 2020 13:58:13 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
		<item>
			<title>Alexis Walker at 14:34, 29 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3202758&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:34, 29 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 15:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 15:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 is bound to five total zinc ions which help to stabilize the DNA during recombination. &amp;lt;scene name='84/842946/Binding_site/1'&amp;gt;Two zinc ions&amp;lt;/scene&amp;gt; (at residues 1487 and 1486) are involved in the DNA binding site. RAG2 contains a PHD near its C-terminus that specifically recognizes a methylated lysine 4 on histone H3. One unique component of the RAG2-PHD complex is that a peptide N-terminal to the RAG2-PHD can bind to the substrate-binding site. The ability of protein segments down the line to bind to an earlier section demonstrates the potential autoregulatory nature of this peptide&amp;lt;ref&amp;gt;Ramon-Maiques, S., et al., The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc Natl Acad Sci U S A, 2007. 104(48): p. 18993-8&amp;lt;/ref&amp;gt;. The peptide is also modified to yield enhanced binding to the H3K4me3. Normal interaction involves a carboxylate with an arginine 2 (R2). The RAG2-PHD replaces this carboxylate with a tyrosine (T445) which gives an interaction that is enhanced by the dimethylation of the R2 rather than inhibited.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 is bound to five total zinc ions which help to stabilize the DNA during recombination. &amp;lt;scene name='84/842946/Binding_site/1'&amp;gt;Two zinc ions&amp;lt;/scene&amp;gt; (at residues 1487 and 1486) are involved in the DNA binding site. RAG2 contains a PHD near its C-terminus that specifically recognizes a methylated lysine 4 on histone H3. One unique component of the RAG2-PHD complex is that a peptide N-terminal to the RAG2-PHD can bind to the substrate-binding site. The ability of protein segments down the line to bind to an earlier section demonstrates the potential autoregulatory nature of this peptide&amp;lt;ref&amp;gt;Ramon-Maiques, S., et al., The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc Natl Acad Sci U S A, 2007. 104(48): p. 18993-8&amp;lt;/ref&amp;gt;. The peptide is also modified to yield enhanced binding to the H3K4me3. Normal interaction involves a carboxylate with an arginine 2 (R2). The RAG2-PHD replaces this carboxylate with a &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;scene name='84/842946/Tyr/2'&amp;gt;&lt;/ins&gt;tyrosine (T445)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/scene&amp;gt; &lt;/ins&gt;which gives an interaction that is enhanced by the dimethylation of the R2 rather than inhibited.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Mechanism of Action==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Mechanism of Action==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 21:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 21:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Evolution ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Evolution ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;205 homologs were found via ConSurf-DB. Within chain A there is one predominant region with high levels of conservation. This region surrounds the N-trimethllysine and is therefore implicated in histone binding. The same levels of conserved residues apply to chain B as well. The level of conservation can be seen here.Throughout multiple species the PHD-zinc finger is conserved, indicating that it is crucial to the function of RAG2. Due to its function, RAG2 is likely conserved across multiple species. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;205 homologs were found via ConSurf-DB. Within chain A there is one predominant region with high levels of conservation. This region surrounds the N-trimethllysine and is therefore implicated in histone binding. The same levels of conserved residues apply to chain B as well. The level of conservation can be seen &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;scene name='84/842946/Conservation/2'&amp;gt;&lt;/ins&gt;here&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/scene&amp;gt;&lt;/ins&gt;. Throughout multiple species the PHD-zinc finger is conserved, indicating that it is crucial to the function of RAG2. Due to its function, RAG2 is likely conserved across multiple species. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Links to 3-D Structures==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Links to 3-D Structures==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Wed, 29 Apr 2020 14:34:09 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
		<item>
			<title>Alexis Walker at 14:27, 29 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3202757&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 14:27, 29 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Insert caption here&lt;/del&gt;' scene='&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Insert optional scene name here&lt;/del&gt;' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;Structure load='2V83' size='500' frame='true' align='right' caption='&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;3-D model of RAG2-PHD&lt;/ins&gt;' scene='&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;2V83&lt;/ins&gt;' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 Recombination Activating Gene 2&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 Recombination Activating Gene 2&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 5:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 5:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Five specific residues were implicated in patients with &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;severe combined immunodeficiency (&lt;/del&gt;SCID&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;)&lt;/del&gt;. These residues are involved in histone recognition &amp;lt;ref&amp;gt;Ramon-Maiques, S., et al., The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc Natl Acad Sci U S A, 2007. 104(48): p. 18993-8&amp;lt;/ref&amp;gt;. One mechanism is in the disruption of the overall protein structure results in T(-)B(-) SCID. This autosomal recessive disease is caused by an inability to form fully mature T- and B-cells, thus rendering them ineffective within the patient. Natural Killer cells are still present within the patient and the thalamus is typically hypoplastic. The condition can usually be treated with a bone marrow transplant&amp;lt;ref&amp;gt;Fischer A. Severe combined immunodeficiencies (SCID). Clin Exp Immunol. 2000;122(2):143–149. doi:10.1046/j.1365-2249.2000.01359.x&amp;lt;/ref&amp;gt;. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Due to the primary function of RAG2 in the immune system, and any level of compromised function can lead to immunodeficiency. Most cases of mutation cause severe combined immunodeficiency (SCID). &lt;/ins&gt;Five specific residues were implicated in patients with SCID. These residues are involved in histone recognition &amp;lt;ref&amp;gt;Ramon-Maiques, S., et al., The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc Natl Acad Sci U S A, 2007. 104(48): p. 18993-8&amp;lt;/ref&amp;gt;. One mechanism is in the disruption of the overall protein structure &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;which &lt;/ins&gt;results in T(-)B(-) SCID. This autosomal recessive disease is caused by an inability to form fully mature T- and B-cells, thus rendering them ineffective within the patient. Natural Killer cells are still present within the patient and the thalamus is typically hypoplastic. The condition can usually be treated with a bone marrow transplant&amp;lt;ref&amp;gt;Fischer A. Severe combined immunodeficiencies (SCID). Clin Exp Immunol. 2000;122(2):143–149. doi:10.1046/j.1365-2249.2000.01359.x&amp;lt;/ref&amp;gt;. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Failure to bind to H3K4me-3 &lt;/del&gt;Omenn Syndrome is a special type of SCID &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;that is usually &lt;/del&gt;classified by a failure to thrive and elevated serum IgE levels. The autosomal recessive disease renders patients with low immunoglobulin levels and no B-cells. There are levels of T-cells in the blood but they are functionally impaired &amp;lt;ref&amp;gt;Aleman K, Noordzij JG, de Groot R, van Dongen JJ, Hartwig NG. Reviewing Omenn syndrome. Eur J Pediatr. 2001; http://www.ncbi.nlm.nih.gov/pubmed/11795679 &amp;lt;/ref&amp;gt;. Hypomorphic mutations of RAG contribute to Omenn Syndrome. Studies have found that a specific W453R mutation alters the readout of H3K4me3 recognition &amp;lt;ref&amp;gt;Matthews AG, Kuo AJ, Ramón-Maiques S, et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature. 2007;450(7172):1106–1110. doi:10.1038/nature06431&amp;lt;/ref&amp;gt;. which is a direct molecular cause of Omenn Syndrome.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Omenn Syndrome is a special type of SCID classified by a &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;failure to bind to H3K4me-3. The patient's usually present with &lt;/ins&gt;failure to thrive and elevated serum IgE levels. The autosomal recessive disease renders patients with low immunoglobulin levels and no B-cells. There are levels of T-cells in the blood but they are functionally impaired &amp;lt;ref&amp;gt;Aleman K, Noordzij JG, de Groot R, van Dongen JJ, Hartwig NG. Reviewing Omenn syndrome. Eur J Pediatr. 2001; http://www.ncbi.nlm.nih.gov/pubmed/11795679 &amp;lt;/ref&amp;gt;. Hypomorphic mutations of RAG contribute to Omenn Syndrome. Studies have found that a specific W453R mutation alters the readout of H3K4me3 recognition &amp;lt;ref&amp;gt;Matthews AG, Kuo AJ, Ramón-Maiques S, et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature. 2007;450(7172):1106–1110. doi:10.1038/nature06431&amp;lt;/ref&amp;gt;. which is a direct molecular cause of Omenn Syndrome.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Interestingly, infants born with the same RAG mutations can develop either SCID or Omenn Syndrome indicating that there may be an environmental component that contributes to disease development. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Interestingly, infants born with the same RAG mutations can develop either SCID or Omenn Syndrome indicating that there may be an environmental component that contributes to disease development. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Structure==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Structure==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 structure is composed of two total entities and five total chains with a sequence length of 527&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(source)&lt;/del&gt;. Within the VDJ Recombination Activating Protein 2 entity, there are a total of &amp;lt;scene name='84/842946/Vdj_component/1'&amp;gt;three chains&amp;lt;/scene&amp;gt;. The second entity is the histone H3 entity. This is the region of the protein that binds to H3. There are a total of &amp;lt;scene name='84/842946/Chains_d_and_e/1'&amp;gt;two histone chains&amp;lt;/scene&amp;gt;. There are a total of two N-trimethyllysines.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 structure is composed of two total entities and five total chains with a sequence length of 527. Within the VDJ Recombination Activating Protein 2 entity, there are a total of &amp;lt;scene name='84/842946/Vdj_component/1'&amp;gt;three chains&amp;lt;/scene&amp;gt;. The second entity is the histone H3 entity. This is the region of the protein that binds to H3. There are a total of &amp;lt;scene name='84/842946/Chains_d_and_e/1'&amp;gt;two histone chains&amp;lt;/scene&amp;gt;. There are a total of two N-trimethyllysines.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:M3L.png | thumb | N-trimethyllysine]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:M3L.png | thumb | N-trimethyllysine]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 is bound to five total zinc ions which help to stabilize the DNA during recombination&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/del&gt;&amp;lt;scene name='84/842946/Binding_site/1'&amp;gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;two of which&lt;/del&gt;&amp;lt;/scene&amp;gt; (at residues 1487 and 1486) are involved in the DNA binding site. RAG2 contains a PHD near its C-terminus that specifically recognizes a methylated lysine 4 on histone H3. One unique component of the RAG2-PHD complex is that &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;an &lt;/del&gt;peptide N-terminal to the RAG2-PHD can bind to the substrate-binding site. The ability of protein segments down the line to bind to an earlier section demonstrates the potential autoregulatory nature of this peptide&amp;lt;ref&amp;gt;Ramon-Maiques, S., et al., The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc Natl Acad Sci U S A, 2007. 104(48): p. 18993-8&amp;lt;/ref&amp;gt;. The peptide is also modified to yield enhanced binding to the H3K4me3. Normal interaction involves a carboxylate with an arginine 2 (R2). The RAG2-PHD replaces this carboxylate with a tyrosine (T445) which gives an interaction that is enhanced by the dimethylation of the R2 rather than inhibited.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 is bound to five total zinc ions which help to stabilize the DNA during recombination&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. &lt;/ins&gt;&amp;lt;scene name='84/842946/Binding_site/1'&amp;gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Two zinc ions&lt;/ins&gt;&amp;lt;/scene&amp;gt; (at residues 1487 and 1486) are involved in the DNA binding site. RAG2 contains a PHD near its C-terminus that specifically recognizes a methylated lysine 4 on histone H3. One unique component of the RAG2-PHD complex is that &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;a &lt;/ins&gt;peptide N-terminal to the RAG2-PHD can bind to the substrate-binding site. The ability of protein segments down the line to bind to an earlier section demonstrates the potential autoregulatory nature of this peptide&amp;lt;ref&amp;gt;Ramon-Maiques, S., et al., The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc Natl Acad Sci U S A, 2007. 104(48): p. 18993-8&amp;lt;/ref&amp;gt;. The peptide is also modified to yield enhanced binding to the H3K4me3. Normal interaction involves a carboxylate with an arginine 2 (R2). The RAG2-PHD replaces this carboxylate with a tyrosine (T445) which gives an interaction that is enhanced by the dimethylation of the R2 rather than inhibited.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Mechanism of Action==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Mechanism of Action==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 contains three residues that are primarily responsible for recognition of the tri-methyllysine present on histone H3. These residues form what is called the aromatic channel and are in positions, 415, 443, and 453 &amp;lt;ref&amp;gt;Matthews AG, Kuo AJ, Ramón-Maiques S, et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature. 2007;450(7172):1106–1110. doi:10.1038/nature06431&amp;lt;/ref&amp;gt;. The tyrosine, methionine and tryptophan residues surround the trimelthyllysine, identifying it for the reaction. Upon recognition the DNA is cleaved in a two-step process. First a nick is introduced at the 5' end of the recognized signal sequence. The complementary strand is then broken yielding a hairpin structure at the coding end&amp;lt;ref&amp;gt; McBlane JF, e., 2020. Cleavage At A V(D)J Recombination Signal Requires Only RAG1 And RAG2 Proteins And Occurs In Two Steps. - Pubmed - NCBI. [online] Ncbi.nlm.nih.gov. Available at: &amp;lt;https://www.ncbi.nlm.nih.gov/pubmed/8521468&amp;gt;&amp;lt;/ref&amp;gt;. Studies have shown that this mechanism can be done by purified forms of RAG1 and RAG2 only.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 contains three residues that are primarily responsible for recognition of the tri-methyllysine present on histone H3. These residues form what is called the aromatic channel and are in positions, 415, 443, and 453 &amp;lt;ref&amp;gt;Matthews AG, Kuo AJ, Ramón-Maiques S, et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature. 2007;450(7172):1106–1110. doi:10.1038/nature06431&amp;lt;/ref&amp;gt;. The tyrosine, methionine&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;and tryptophan residues surround the trimelthyllysine, identifying it for the reaction. Upon recognition&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;the DNA is cleaved in a two-step process. First&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;a nick is introduced at the 5' end of the recognized signal sequence. The complementary strand is then broken yielding a hairpin structure at the coding end&amp;lt;ref&amp;gt; McBlane JF, e., 2020. Cleavage At A V(D)J Recombination Signal Requires Only RAG1 And RAG2 Proteins And Occurs In Two Steps. - Pubmed - NCBI. [online] Ncbi.nlm.nih.gov. Available at: &amp;lt;https://www.ncbi.nlm.nih.gov/pubmed/8521468&amp;gt;&amp;lt;/ref&amp;gt;. Studies have shown that this mechanism can be done by purified forms of RAG1 and RAG2 only.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Evolution ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Evolution ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;205 homologs were found via ConSurf-DB. Within chain A there is one predominant region with high levels of conservation. This region surrounds the N-trimethllysine. The same levels of conserved residues apply to chain B as well. Throughout multiple species the PHD-zinc finger is conserved, indicating that it is crucial to the function of RAG2. Due to its function, RAG2 is likely conserved across multiple species. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;205 homologs were found via ConSurf-DB. Within chain A there is one predominant region with high levels of conservation. This region surrounds the N-trimethllysine &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;and is therefore implicated in histone binding&lt;/ins&gt;. The same levels of conserved residues apply to chain B as well&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. The level of conservation can be seen here&lt;/ins&gt;.Throughout multiple species the PHD-zinc finger is conserved, indicating that it is crucial to the function of RAG2. Due to its function, RAG2 is likely conserved across multiple species. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Links to 3-D Structures==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Links to 3-D Structures==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Wed, 29 Apr 2020 14:27:40 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
		<item>
			<title>Alexis Walker at 13:58, 29 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3202755&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 13:58, 29 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 Recombination Activating Gene 2&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 Recombination Activating Gene 2&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key nuclear protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(&lt;/del&gt;Sadofsky). RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key nuclear protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;&lt;/ins&gt;Sadofsky &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;MJ. The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res. 2001;29(7&lt;/ins&gt;)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;:1399–1409. doi:10.1093/nar/29.7.1399&amp;lt;/ref&amp;gt;&lt;/ins&gt;. RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Five specific residues were implicated in patients with severe combined immunodeficiency (SCID). These residues are involved in histone recognition&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. (Ramón&lt;/del&gt;-Maiques) One mechanism is in the disruption of the overall protein structure results in T(-)B(-) SCID. This autosomal recessive disease is caused by an inability to form fully mature T- and B-cells, thus rendering them ineffective within the patient. Natural Killer cells are still present within the patient and the thalamus is typically hypoplastic. The condition can usually be treated with a bone marrow transplant. (&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Fischer&lt;/del&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Five specific residues were implicated in patients with severe combined immunodeficiency (SCID). These residues are involved in histone recognition &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Ramon&lt;/ins&gt;-Maiques&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, S., et al., The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc Natl Acad Sci U S A, 2007. 104(48&lt;/ins&gt;)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;: p. 18993-8&amp;lt;/ref&amp;gt;. &lt;/ins&gt;One mechanism is in the disruption of the overall protein structure results in T(-)B(-) SCID. This autosomal recessive disease is caused by an inability to form fully mature T- and B-cells, thus rendering them ineffective within the patient. Natural Killer cells are still present within the patient and the thalamus is typically hypoplastic. The condition can usually be treated with a bone marrow transplant&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Fischer A&lt;/ins&gt;. &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Severe combined immunodeficiencies &lt;/ins&gt;(&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;SCID&lt;/ins&gt;)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. Clin Exp Immunol. 2000;122(2):143–149. doi:10.1046/j.1365-2249.2000.01359.x&amp;lt;/ref&amp;gt;. &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Failure to bind to H3K4me-3 Omenn Syndrome is a special type of SCID that is usually classified by a failure to thrive and elevated serum IgE levels. The autosomal recessive disease renders patients with low immunoglobulin levels and no B-cells. There are levels of T-cells in the blood but they are functionally impaired&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. (&lt;/del&gt;Aleman&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;) &lt;/del&gt;Hypomorphic mutations of RAG contribute to Omenn Syndrome. Studies have found that a specific W453R mutation alters the readout of H3K4me3 recognition (&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Matthews2&lt;/del&gt;)&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/del&gt;which is a direct molecular cause of Omenn Syndrome.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Failure to bind to H3K4me-3 Omenn Syndrome is a special type of SCID that is usually classified by a failure to thrive and elevated serum IgE levels. The autosomal recessive disease renders patients with low immunoglobulin levels and no B-cells. There are levels of T-cells in the blood but they are functionally impaired &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;&lt;/ins&gt;Aleman &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;K, Noordzij JG, de Groot R, van Dongen JJ, Hartwig NG. Reviewing Omenn syndrome. Eur J Pediatr. 2001; http://www.ncbi.nlm.nih.gov/pubmed/11795679 &amp;lt;/ref&amp;gt;. &lt;/ins&gt;Hypomorphic mutations of RAG contribute to Omenn Syndrome. Studies have found that a specific W453R mutation alters the readout of H3K4me3 recognition &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Matthews AG, Kuo AJ, Ramón-Maiques S, et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V&lt;/ins&gt;(&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;D&lt;/ins&gt;)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;J recombination. Nature. 2007;450(7172):1106–1110. doi:10.1038/nature06431&amp;lt;/ref&amp;gt;. &lt;/ins&gt;which is a direct molecular cause of Omenn Syndrome.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Interestingly, infants born with the same RAG mutations can develop either SCID or Omenn Syndrome indicating that there may be an environmental component that contributes to disease development. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Interestingly, infants born with the same RAG mutations can develop either SCID or Omenn Syndrome indicating that there may be an environmental component that contributes to disease development. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 14:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 14:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 is bound to five total zinc ions which help to stabilize the DNA during recombination, &amp;lt;scene name='84/842946/Binding_site/1'&amp;gt;two of which&amp;lt;/scene&amp;gt; (at residues 1487 and 1486) are involved in the DNA binding site. RAG2 contains a PHD near its C-terminus that specifically recognizes a methylated lysine 4 on histone H3. One unique component of the RAG2-PHD complex is that an peptide N-terminal to the RAG2-PHD can bind to the substrate-binding site. The ability of protein segments down the line to bind to an earlier section demonstrates the potential autoregulatory nature of this peptide&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(Ramón&lt;/del&gt;-Maiques). The peptide is also modified to yield enhanced binding to the H3K4me3. Normal interaction involves a carboxylate with an arginine 2 (R2). The RAG2-PHD replaces this carboxylate with a tyrosine (T445) which gives an interaction that is enhanced by the dimethylation of the R2 rather than inhibited.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 is bound to five total zinc ions which help to stabilize the DNA during recombination, &amp;lt;scene name='84/842946/Binding_site/1'&amp;gt;two of which&amp;lt;/scene&amp;gt; (at residues 1487 and 1486) are involved in the DNA binding site. RAG2 contains a PHD near its C-terminus that specifically recognizes a methylated lysine 4 on histone H3. One unique component of the RAG2-PHD complex is that an peptide N-terminal to the RAG2-PHD can bind to the substrate-binding site. The ability of protein segments down the line to bind to an earlier section demonstrates the potential autoregulatory nature of this peptide&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Ramon&lt;/ins&gt;-Maiques&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, S., et al., The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc Natl Acad Sci U S A, 2007. 104(48&lt;/ins&gt;)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;: p. 18993-8&amp;lt;/ref&amp;gt;&lt;/ins&gt;. The peptide is also modified to yield enhanced binding to the H3K4me3. Normal interaction involves a carboxylate with an arginine 2 (R2). The RAG2-PHD replaces this carboxylate with a tyrosine (T445) which gives an interaction that is enhanced by the dimethylation of the R2 rather than inhibited.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Mechanism of Action==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Mechanism of Action==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 contains three residues that are primarily responsible for recognition of the tri-methyllysine present on histone H3. These residues form what is called the aromatic channel and are in positions, 415, 443, and 453 (&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Matthews2&lt;/del&gt;). The tyrosine, methionine and tryptophan residues surround the trimelthyllysine, identifying it for the reaction. Upon recognition the DNA is cleaved in a two-step process. First a nick is introduced at the 5' end of the recognized signal sequence. The complementary strand is then broken yielding a hairpin structure at the coding end &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(&lt;/del&gt;McBlane). Studies have shown that this mechanism can be done by purified forms of RAG1 and RAG2 only.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 contains three residues that are primarily responsible for recognition of the tri-methyllysine present on histone H3. These residues form what is called the aromatic channel and are in positions, 415, 443, and 453 &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt;Matthews AG, Kuo AJ, Ramón-Maiques S, et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V&lt;/ins&gt;(&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;D&lt;/ins&gt;)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;J recombination. Nature. 2007;450(7172):1106–1110. doi:10.1038/nature06431&amp;lt;/ref&amp;gt;&lt;/ins&gt;. The tyrosine, methionine and tryptophan residues surround the trimelthyllysine, identifying it for the reaction. Upon recognition the DNA is cleaved in a two-step process. First a nick is introduced at the 5' end of the recognized signal sequence. The complementary strand is then broken yielding a hairpin structure at the coding end&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref&amp;gt; &lt;/ins&gt;McBlane &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;JF, e., 2020. Cleavage At A V(D&lt;/ins&gt;)&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;J Recombination Signal Requires Only RAG1 And RAG2 Proteins And Occurs In Two Steps. - Pubmed - NCBI. [online] Ncbi.nlm.nih.gov. Available at: &amp;lt;https://www.ncbi.nlm.nih.gov/pubmed/8521468&amp;gt;&amp;lt;/ref&amp;gt;&lt;/ins&gt;. Studies have shown that this mechanism can be done by purified forms of RAG1 and RAG2 only.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Evolution ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Evolution ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 26:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 26:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.rcsb.org/structure/4WWX RAG 1/2 Core structure]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.rcsb.org/structure/4WWX RAG 1/2 Core structure]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.rcsb.org/structure/2V83 RAG2-PHD 2V83]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[https://www.rcsb.org/structure/2V83 RAG2-PHD 2V83]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Wed, 29 Apr 2020 13:58:00 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
		<item>
			<title>Alexis Walker at 16:53, 28 April 2020</title>
			<link>http://52.214.119.220/wiki/index.php?title=User:Alexis_Walker/Sandbox_1&amp;diff=3199395&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 16:53, 28 April 2020&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 Recombination Activating Gene 2&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 Recombination Activating Gene 2&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Function ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity (Sadofsky). RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Recombination activating gene (RAG) 2  is a key &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;nuclear &lt;/ins&gt;protein in the rearrangement and recombination of genes that encode immunoglobulins and T-cell receptors. Both RAG1 and RAG2 form a V(D)J recombinase complex that is essential in maturing B- and T-cells, both of which are critical for adaptive immunity (Sadofsky). RAG cleaves dsDNA between the antigen receptor and the recombination signal sequence. These segments are then rejoined in a variable fashion that allows for the diversity within an organism's immune system. The recombination allows for the T- and B-cells to mature and ultimately act in their specified manner. More specifically RAG2 has a plant homeodomain (PHD) that recognizes a methylated lysine on histone H3. This domain is crucial to the function of RAG.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Disease ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Five specific residues were implicated in patients with severe combined immunodeficiency (SCID). These residues are involved in histone recognition. (Ramón-Maiques) One mechanism is in the disruption of the overall protein structure results in T(-)B(-) SCID. This autosomal recessive disease is caused by an inability to form fully mature T- and B-cells, thus rendering them ineffective within the patient. Natural Killer cells are still present within the patient and the thalamus is typically hypoplastic. The condition can usually be treated with a bone marrow transplant. (Fischer)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Five specific residues were implicated in patients with severe combined immunodeficiency (SCID). These residues are involved in histone recognition. (Ramón-Maiques) One mechanism is in the disruption of the overall protein structure results in T(-)B(-) SCID. This autosomal recessive disease is caused by an inability to form fully mature T- and B-cells, thus rendering them ineffective within the patient. Natural Killer cells are still present within the patient and the thalamus is typically hypoplastic. The condition can usually be treated with a bone marrow transplant. (Fischer)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Failure to bind to H3K4me-3 Omenn Syndrome is a special type of SCID that is usually classified by a failure to thrive and elevated serum IgE levels. The autosomal recessive disease renders patients with low immunoglobulin levels and no B-cells. There are levels of T-cells in the blood but they are functionally impaired. (Aleman) Hypomorphic mutations of RAG contribute to Omenn Syndrome&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;/&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Failure to bind to H3K4me-3 Omenn Syndrome is a special type of SCID that is usually classified by a failure to thrive and elevated serum IgE levels. The autosomal recessive disease renders patients with low immunoglobulin levels and no B-cells. There are levels of T-cells in the blood but they are functionally impaired. (Aleman) Hypomorphic mutations of RAG contribute to Omenn Syndrome&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. Studies have found that a specific W453R mutation alters the readout of H3K4me3 recognition (Matthews2), which is a direct molecular cause of Omenn Syndrome.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Interestingly, infants born with the same RAG mutations can develop either SCID or Omenn Syndrome indicating that there may be an environmental component that contributes to disease development. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;Interestingly, infants born with the same RAG mutations can develop either SCID or Omenn Syndrome indicating that there may be an environmental component that contributes to disease development. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Structure==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Structure==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 structure is composed of two total entities and five total chains. Within the VDJ Recombination Activating Protein 2 entity, there are a total of &amp;lt;scene name='84/842946/Vdj_component/1'&amp;gt;three chains&amp;lt;/scene&amp;gt;. The second entity is the histone H3 entity. This is the region of the protein that binds to H3. There are a total of &amp;lt;scene name='84/842946/Chains_d_and_e/1'&amp;gt;two histone chains&amp;lt;/scene&amp;gt;. There are a total of two N-trimethyllysines.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;2V83 structure is composed of two total entities and five total chains &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;with a sequence length of 527(source)&lt;/ins&gt;. Within the VDJ Recombination Activating Protein 2 entity, there are a total of &amp;lt;scene name='84/842946/Vdj_component/1'&amp;gt;three chains&amp;lt;/scene&amp;gt;. The second entity is the histone H3 entity. This is the region of the protein that binds to H3. There are a total of &amp;lt;scene name='84/842946/Chains_d_and_e/1'&amp;gt;two histone chains&amp;lt;/scene&amp;gt;. There are a total of two N-trimethyllysines.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:M3L.png | thumb | N-trimethyllysine]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Image:M3L.png | thumb | N-trimethyllysine]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Structural highlights ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 is bound to five total zinc ions which help to stabilize the DNA during recombination, &amp;lt;scene name='84/842946/Binding_site/1'&amp;gt;two of which&amp;lt;/scene&amp;gt; (at residues 1487 and 1486) are involved in the DNA binding site. RAG2 contains a PHD near its C-terminus that specifically recognizes a methylated lysine 4 on histone H3. One unique component of the RAG2-PHD complex is that an peptide N-terminal to the RAG2-PHD can bind to the substrate-binding site. The ability of protein segments down the line to bind to an earlier section demonstrates the potential autoregulatory nature of this peptide(Ramón-Maiques). The peptide is also modified to yield enhanced binding to the H3K4me3. Normal interaction involves a carboxylate with an arginine 2 (R2). The RAG2-PHD replaces this carboxylate with a tyrosine (T445) which gives an interaction that is enhanced by the dimethylation of the R2 rather than inhibited.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 is bound to five total zinc ions which help to stabilize the DNA during recombination, &amp;lt;scene name='84/842946/Binding_site/1'&amp;gt;two of which&amp;lt;/scene&amp;gt; (at residues 1487 and 1486) are involved in the DNA binding site. RAG2 contains a PHD near its C-terminus that specifically recognizes a methylated lysine 4 on histone H3. One unique component of the RAG2-PHD complex is that an peptide N-terminal to the RAG2-PHD can bind to the substrate-binding site. The ability of protein segments down the line to bind to an earlier section demonstrates the potential autoregulatory nature of this peptide(Ramón-Maiques). The peptide is also modified to yield enhanced binding to the H3K4me3. Normal interaction involves a carboxylate with an arginine 2 (R2). The RAG2-PHD replaces this carboxylate with a tyrosine (T445) which gives an interaction that is enhanced by the dimethylation of the R2 rather than inhibited.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==Mechanism of Action==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;RAG2 contains three residues that are primarily responsible for recognition of the tri-methyllysine present on histone H3. These residues form what is called the aromatic channel and are in positions, 415, 443, and 453 (Matthews2). The tyrosine, methionine and tryptophan residues surround the trimelthyllysine, identifying it for the reaction. Upon recognition the DNA is cleaved in a two-step process. First a nick is introduced at the 5' end of the recognized signal sequence. The complementary strand is then broken yielding a hairpin structure at the coding end (McBlane). Studies have shown that this mechanism can be done by purified forms of RAG1 and RAG2 only.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Evolution ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;== Evolution ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 28 Apr 2020 16:53:22 GMT</pubDate>			<dc:creator>Alexis Walker</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/User_talk:Alexis_Walker/Sandbox_1</comments>		</item>
	</channel>
</rss>